Paris, France

Françoise Bono

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 5.1

ph-index = 4

Forward Citations = 22(Granted Patents)


Location History:

  • Toulouse, FR (2007 - 2008)
  • Paris, FR (2012 - 2013)

Company Filing History:


Years Active: 2007-2013

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Françoise Bono: Innovator in Therapeutics

Introduction

Françoise Bono is a notable inventor based in Paris, France. He has made significant contributions to the field of therapeutics, holding a total of four patents. His work focuses on innovative compounds that have potential applications in medical treatments.

Latest Patents

Bono's latest patents include "Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics." This patent discloses 7-alkynyl-1,8-naphthyridones, detailing their formula and therapeutic applications. Another significant patent is "Derivatives of (bridged piperazinyl)-1-alkanone and use thereof as p75 inhibitors." This invention relates to derivatives of specific compounds and their therapeutic uses, showcasing Bono's focus on developing new treatment options.

Career Highlights

Throughout his career, Françoise Bono has worked with prominent companies in the pharmaceutical industry, including Sanofi and Sanofi-Aventis. His experience in these organizations has allowed him to contribute to various innovative projects and advancements in therapeutics.

Collaborations

Bono has collaborated with notable colleagues, including Michaël Bosch and Victor Dos Santos. These partnerships have likely enhanced his research and development efforts, leading to successful patent applications.

Conclusion

Françoise Bono is a distinguished inventor whose work in therapeutics has led to multiple patents and collaborations with industry leaders. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…